A real-world study of pegcetacoplan for treatment of geographic atrophy showed significantly better outcomes than the pivotal clinical trials in patients who had symptomatic vision loss.
The CHMP initially adopted a negative opinion in January after finding it was unable to establish a positive balance of benefits and risks for Syfovre, but Apellis sought a re-examination and was able ...
Sobi, Enable Injections ink agreement to develop and distribute Aspaveli in combination with enFuse in Sobi territories: Sweden Saturday, September 14, 2024, 10:00 Hrs [IST] Sobi, ...
Some results have been hidden because they may be inaccessible to you